Understanding Oncology Nursing Assessment
Oncology is the branch of medicine concerned with the prevention, diagnosis, treatment and study of cancer. Cancer is a group of diseases driven by uncontrolled cell proliferation, local tissue invasion and the potential to spread (metastasise) to distant sites. Carcinogenesis reflects accumulated genetic and epigenetic changes affecting oncogenes, tumour suppressor genes and DNA repair pathways. Tumours can be benign (non-invasive, localised) or malignant (invasive, metastatic), and behaviour varies widely between cancer types and stages.
Cancers can affect any body system, so presentations are diverse: unexplained weight loss, persistent fatigue, fever, pain, skin or mole changes, altered bowel or bladder habits, persistent cough or hoarseness, abnormal bleeding or discharge, palpable lumps and dysphagia. Nursing assessment combines a structured history (smoking, alcohol, infections such as HPV/HBV/HCV/H. pylori/EBV, occupational and environmental exposures, family history, reproductive factors), focused examination (lymph nodes, masses, organomegaly, skin), and timely investigations including imaging (US, CT, MRI, PET-CT), tumour markers and tissue biopsy for histology and molecular profiling.
Common cancers worldwide include lung, breast, colorectal, prostate, stomach, liver, cervical, oesophageal, thyroid, bladder, melanoma, lymphomas, leukaemias and head and neck cancers. Treatment is increasingly multimodal — surgery, radiotherapy, chemotherapy, immunotherapy, targeted therapy, hormone therapy and stem cell transplantation — and is guided by international staging systems and biomarkers (e.g. HER2, EGFR, PD-L1, BRCA1/2). Oncology nursing spans the whole cancer continuum: prevention and screening, diagnosis and staging, treatment delivery and symptom management, survivorship, and palliative and end-of-life care.
Core oncology concepts
Cancer staging uses the TNM system (Tumour, Node, Metastasis) with stage groupings 0–IV; tumour grading describes differentiation. Recognised oncologic emergencies include febrile neutropenia, tumour lysis syndrome, superior vena cava syndrome, malignant spinal cord compression, hypercalcaemia of malignancy and immune-related adverse events from checkpoint inhibitors. Treatment toxicities — myelosuppression (anaemia, neutropenia, thrombocytopenia), nausea and vomiting, mucositis, diarrhoea, alopecia, fatigue, peripheral neuropathy, cardiotoxicity and immunotherapy-related endocrinopathies — drive much of inpatient and outpatient nursing workload. Palliative care is integrated early to optimise symptom control, psychosocial support and advance care planning.
🚨 Oncologic red flags — escalate immediately
- Febrile neutropenia – temperature ≥38.0 °C with absolute neutrophil count <0.5×10⁹/L (or <1.0×10⁹/L falling); medical emergency, blood cultures and IV antibiotics within 1 hour.
- Malignant spinal cord compression – new or progressive back pain with weakness, sensory level or bladder/bowel dysfunction in any patient with known or suspected cancer; urgent MRI and steroids.
- Superior vena cava (SVC) syndrome – facial/neck swelling, dyspnoea, distended neck and chest wall veins, upper-limb oedema; urgent imaging and oncology review.
- Tumour lysis syndrome – nausea, vomiting, weakness, arrhythmias or seizures with rising potassium, phosphate, urate or creatinine, especially in haematological malignancies starting therapy.
- Hypercalcaemia of malignancy – confusion, weakness, polyuria, constipation, dehydration; urgent rehydration, bisphosphonate or denosumab.
- Severe immune-related adverse events – pneumonitis, colitis, hepatitis, endocrinopathy or myocarditis on checkpoint inhibitors; pause therapy and escalate per protocol.
Rapid Assessment Pathways
Suspicious Mass / Lesion
- Site, size, consistency, mobility, tenderness, overlying skin
- Duration, growth rate, B symptoms (weight loss, fever, night sweats)
- Risk factors: age, family history, smoking, alcohol, occupational and viral exposures
- Imaging (US, CT, MRI, PET-CT) for characterisation and staging
- Tissue diagnosis: core, excisional or image-guided biopsy with molecular profiling
Unexplained Bleeding
- Haemoptysis (lung), haematemesis/melaena (GI), haematuria (urological), postmenopausal bleeding (endometrial)
- Bloody nipple discharge or breast lump (breast)
- Petechiae, bruising, mucosal bleeding (leukaemia, marrow failure)
- FBC, coagulation, urgent endoscopy/cystoscopy or imaging as guided
- Tissue biopsy of any identified mass or suspicious mucosal lesion
Treatment Side Effects
- Myelosuppression: infection (fever), bleeding, anaemia, fatigue
- Gastrointestinal: nausea, vomiting, mucositis, diarrhoea, constipation
- Neurological: peripheral neuropathy (taxanes, platinums, vinca alkaloids)
- Cardiac: heart failure (anthracyclines, trastuzumab), QT prolongation
- Dermatological: hand–foot syndrome, rash, photosensitivity, alopecia
Oncologic Emergency
- Febrile neutropenia: fever, chills, hypotension, sepsis screen and antibiotics
- Cord compression: back pain, weakness, sensory level, bladder dysfunction
- SVC syndrome: facial swelling, dyspnoea, distended neck veins
- Tumour lysis: K⁺, phosphate, urate, creatinine, ECG, hydration ± rasburicase
- Hypercalcaemia: confusion, weakness, polyuria, IV fluids and bisphosphonate
Oncologic Symptoms
Explore the signs and symptoms directory for additional published resources.
Cancer Types & Conditions
Oncology Nursing Procedures
Explore the nursing procedures directory for additional published resources.
Diagnostic Tests
Cancer Medications
Related Body Systems
▶ References & Guidelines
- World Health Organization (WHO). Cancer fact sheet and global action plans.
- International Agency for Research on Cancer (IARC). Global Cancer Observatory (GLOBOCAN) incidence and mortality data.
- Union for International Cancer Control (UICC). TNM classification of malignant tumours and global resources.
- European Society for Medical Oncology (ESMO). ESMO clinical practice guidelines.
- National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology.
- American Society of Clinical Oncology (ASCO). ASCO clinical practice guidelines.
- National Institute for Health and Care Excellence (NICE, UK). Cancer guidance.
- Cancer Research UK. Health professional resources and statistics.
- Lancet Global Burden of Disease (GBD). Global burden of cancer estimates.
- Oncology Nursing Society (ONS) & European Oncology Nursing Society (EONS). International oncology nursing education and standards.
Explore the full Medical Library
Browse all systems, conditions, symptoms, procedures, tests, and medications across the NurseOnShift clinical reference library.
Open Medical Library→